Abstract
In this paper I deal with ethical factors surrounding germline gene therapy. Such implications include intergenerational responsibility, human dignity, moral status of embryos and so on. I will explore the relevance of the above mentioned issues to discuss the ethical implication of human germline gene therapy (HGLT). We will see that most of arguments claimed by bioethicists do not provide valid reason to oppose HGLT. I will propose an alternative view, based on personal identity issues, to discuss the ethics of human inheritable gene modification.
Similar content being viewed by others
REFERENCES
Anderson WF. Prospects for human gene therapy. Science 1984; 226: 401–409.
Barbour V. The balance of risk and benefit in gene-therapy. The Lancet 2000; 353: 384.
Cohen P. Double trouble. New Scientist, 5 February 2000: 4.
Couzin J. RAC confronts in utero gene therapy proposals. Science 1998; 282: 27.
Dutton G. Debating gene therapy's future. Genetic Engineering News 2000; 1(1): 1–11.
Fiamminghi C. Bioetica. Le Science 1997.
Fluss S. International Guidelines on Bioethics, EFGCP News Kessel-Lo, 1998.
Frankel M. Chapman A. AAAS Report: Human Inheritable Genetic Modifications Assessing Scientific, Ethical, Religious, and Policy Issues, http://www.aaas.org/spp/ dspp/sfrl/germline/main.htm.
Gordon J. Genetic enhancement in humans. Science 1999; (283): 2023–2024.
Harris J. Superman and Wonderwomen: The Ethics of Human Biotechnology. Oxford: Oxford University Press, 1992.
Harris J. The Value of Life. London: Routledge & Kegan Paul, 1984.
Juengst E. Should we treat the human germ-line as a global human resource? In Aguis E. and Salvino Busuttil, eds. Germ-Line Intervention and Our Responsibilities to Future Generations. Great Britain: Kluwer Academic Publishers, 1998.
Kurilo L. Nature and status of embryo, the scientific aspects. In Medically Assisted Procreation and the Protection of Human Embryo. Strasbourg: Council of Europe, 1998.
Lewontin R. Gene, Organismo e Ambiente. Roma: Editori Laterza, 1998.
Madden D. A comparative legal analysis of IVF and the status of human embryos. Biosciences and the Law 1998; 1: 387–403.
Marshall E. Gene therapy death prompts review of adenovirus vector. Science 1999; 286: 2244–2245.
Mauron A. The human embryo and the relativity of biological individuality. In Evans, ed. Conceiving the Embryo. The Hague/London/Boston: Martinus Nijhoff, 1996, pp. 55–74.
McLaren A. IVF: regulation or prohibition? Nature 1989; 342: 6249.
Mori M. On the concept of Pre-embryo. In Harris J. and Holm S. eds. The Future of Human Reproduction. Oxford: Oxford University Press, 1999, pp. 38–54.
Nozick R. Philosophical Explanations. Oxford: Harvard University Press, 1981.
Parfit D. Reasons and Persons. Oxford: Oxford University Press, 1984.
Salvi M. Biotecnologie e bioetica, un ritorno alla metafisica? Terapia genica in utero, clonazione umana e lo statuto morale dell'embrione. Parole Chiave, 2000.
Salvi M. Genetics' Dreams in the post-genomics era. Journal of Medical Ethics, 2001 (in press).
Salvi M. How calculating the utility of human germline gene transformations? A critic to the utilitarianism in bioethics. EJAIB Journal of Asian and International Bioethics 1997; 7: 36–38.
Salvi M. Human genetics and the integrity of self: germline gene therapy. In Macer D. Fujiki N., eds. Bioethics in Asia. Cristchurch NZ, 1998, pp. 278–284.
Salvi M. Ontology and bioethics, the case of human dignity principle in human genetics. EJAIB 1998; 8(6): 181–183.
Sgreccia E. Manuale di Bioetica. Milano: Vita e pensiero, 1986.
Singer P. et al. Embryo Experimentation. N.Y.: Cambridge University Press, 1990.
Singer P. Practical Ethics, 2nd ed. N.Y.: Cambridge University Press, 1993.
Smaglick P. Animal studies boost gene therapy vector's prospects. The scientist 1999; 13(8): 9.
Suzuki D. Knudson P. Genethics, the Ethics of Engineering Life. Toronto: Stoddart, 1987.
Taylor R. (1998) Superhumans. New Scientist, 1998 (3 October): 25–29.
Wadman M. (1998) NIH launches discussion of in utero gene therapy. Nature 1998; 393: 420.
Walters L. Ethical issues in human gene therapy. Human genome News 1999; 10(1-2): 16–17.
Wood-Haper J.Manipulation of the germ line; toward elimination of major infectious diseases? In Harris J. Dyson A., eds. Ethics and Biotechnology. London and N.Y.: Routledge, 1994.
Zanjani E. Anderson F. Prospects for in utero human gene therapy. Science 1999; 285: 2084–2087.
Zohar N. Commentary on ‘Genetic harm: bitten by the body that keeps you?’ Bioethics 1991; 5: 309–311.
Peters T. Playing God and germline intervention Journal of Medicine and Philosophy 1995; 20: 365–386.
Rights and permissions
About this article
Cite this article
Salvi, M. Shaping Individuality: Human Inheritable Germ Line Gene Modification. Theor Med Bioeth 22, 527–542 (2001). https://doi.org/10.1023/A:1014496531938
Issue Date:
DOI: https://doi.org/10.1023/A:1014496531938